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Background: The development of new therapeutics has led to progress in the early management of congenital
diaphragmatic hernia (CDH) in pediatric intensive care units (PICU). Little is known about the impact on the
quality of life (QoL) of children and their family. The aim of this study was to assess the impact of CDH treated
according to the most recent concepts and methods outlined above on child survivors’ QoL and their
parents’ QoL.
Patients and methods: This study incorporated a cross-sectional design performed in two PICU (Marseille,
France). Families of CDH survivors born between 1999 and 2008 were eligible. The following data were recorded:
socio-demographics, antenatal history and delivery, initial hospitalization history. Self-reported data were
collected by mail, including current clinical problems of the children (13-symptom list), children’s QoL
(Kidscreen-27 questionnaire), and parents’ QoL (Short-Form 36 questionnaire). Children’s QoL score was
compared with controls and QoL of survivors of childhood leukemia. Parent’s QoL was compared with controls.
Non-parametric statistics were employed.
Results: Forty-two families agreed to participate and questionnaires were completed by 32 of them. Twenty-one
children had a current clinical problems related to CDH. All the QoL scores of CHD survivors were significantly
lower compared with controls. The physical well-being dimension was significantly higher for CHD survivors
compared with survivors of childhood leukemia. Gastro-esophageal reflux at discharge, antenatal diagnosis,
length of stay in the PICU, and neuropsychological and respiratory issues significantly impacted QoL scores of
children. The parents of CHD survivors had significantly poorer score in emotional role dimension compared
with controls.
Conclusion: The impact of CDH on QoL seems to be important and must be understood by clinicians who treat
these children and their parents.
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Congenital diaphragmatic hernia (CDH) is a rare but se-
vere congenital malformation [1]. Advances in prenatal
imaging have allowed for better estimating the severity
and prognosis before birth according to criteria evaluat-
ing lung volume. Additionally, a better understanding of* Correspondence: fabrice.michel@ap-hm.fr
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reproduction in any medium, provided the orpathophysiology and the development of new therapeu-
tics has led to progress in the early management of
CDH in pediatric intensive care units [2]. Since 1990,
stabilization before surgery, protective mechanical venti-
lation, permissive hypercapnia, high-frequency oscilla-
tion, inhaled nitric oxide (INO) and other vasodilator
drugs for pulmonary hypertension have been developed
[3] and are the clinician’s common weapons [4]. When
extracorporeal membrane oxygenation (ECMO) is avail-
able, some units can use it as rescue therapy. Despite
this progress, the mortality rate reported by most of theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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50%, reflecting the severity of the disease [5]. Furthermore,
recent studies showed that persistent pulmonary hyper-
tension, pulmonary hypoplasia, and non-life-threatening
associated malformations are responsible for important
morbidity in survivors [6]. The most frequent disorders
are pulmonary issues associated with dyspnea, broncho-
spasm, chronic lung disease, prolonged oxygen delivery
and/or tracheotomy [7], gastrointestinal issues, including
a particularly high incidence of gastroesophageal reflux
(GER) disease [8], and neurocognitive and behavioral dis-
orders in some serious cases [9]. Psychological disorders,
growth failure, hearing loss and musculoskeletal abnor-
malities are also frequent in survivors [6,8,10,11]. Al-
though all these issues have been widely reported, little is
known about their impact on the quality of life (QoL) of
children and their family.
To our knowledge, only 4 previous studies have specific-
ally explored the QoL of CDH survivors. One concerned
only adults [12], and 3 explored the QoL of children or
their parents [13-15]. While adult survivors have a similar
QoL as other adults, the studies focusing on children’s
QoL have revealed significantly lower QoL level compared
to controls [13] and norms [15]. A study that evaluated
the impact on family and parental well-being [14] showed
that the presence of medical issues in children was asso-
ciated with a greater impairment of family functioning. No
authors have explored QoL of a homogeneous group of
CDH survivors treated according to the most recent thera-
peutic management [4]. These new concepts are probably
associated with better outcome, with particularly less re-
spiratory sequelae. And the other hand, possibly, higher sur-
vival rate of children with severe disease, can lead to higher
risk of major respiratory, neurologic, digestive, orthopedic,
psychological or others sequelae impacting QoL.
The main objective of our study was to assess the im-
pact of CDH treated according to the most recent con-
cepts and methods outlined above on child survivors’
QoL and their parents’ QoL. The secondary objectives
were first, to compare QoL levels of the CDH survivors
with those observed in the general population and an-
other pathology associated with long-term consequences
(childhood leukemia survivors), and second, to deter-
mine the impact of clinical and socio-demographic fac-
tors on children’s and parents’ QoL scores.
Methods
Study design and population
This study incorporated a cross-sectional design and
was performed in two pediatric intensive care units of a
French public academic teaching hospital (Marseille,
France). The inclusion criteria were as follows: children
with a diagnosis of CDH born between January 1997
and December 2008 who were initially treated accordingto concepts and methods developed during the nineties
(i.e., protective mechanical ventilation, including permis-
sive hypercapnia and preoperative stabilization, INO
availability) and parents or legal guardians authorizing
participation in the study and child consent if older than
6. When the diagnosis of CDH was made after discharge
of maternity the patient was excluded. According to
French law, the Consultative Committee for the data
processing in health research (CCTIRS) approved this
research, and no more authorizations were requested for
this study. The medical database allowed for identifying
the eligible children according to the selection criteria.
Mail was sent to the parents describing the objectives of
the study. In cases of participation acceptance, the par-
ents returned written consent. Questionnaires were sub-
sequently sent by mail.
Medical records
The following data were collected from the medical re-
cords: 1. sociodemographic: age and gender of the child; 2.
antenatal history and delivery: prenatal diagnosis (yes/no),
birth term, birth weight, and caesarean (yes/no); and 3. ini-
tial hospitalization history: CDH side (left/right), date and
nature of the initial surgery (simple/not simple, ie, requir-
ing progressive closure and/or requiring a patch), initial
administration (yes/no) and administration duration of sur-
factant, amines, and INO, mechanical ventilation duration,
sedation duration, need for ECMO and duration, initial
pediatric intensive care unit (PICU) and hospitalization
duration, weight at discharge, and GER at discharge.
Self-reported data
Self-reported data were collected from the children them-
selves and their parents. The following self-reported data
were collected from the parents:
1. Current staturo-ponderal information: weight and
body mass index Z-score.
2. Current clinical problems caused by CDH: the
parents were questioned about the frequency (never
or sometimes/frequent or very frequent) of current
clinical problems using a checklist exploring 13
symptoms in 4 main clinical domains: digestive
symptoms (vomiting, reflux, retrosternal burning,
constipation, diarrhea, and abdominal pain),
respiratory symptoms (dyspnea at rest, exertional
dyspnea, nocturnal dyspnea, chest pain, repeated
respiratory tract infection, hospitalization for
respiratory issue, and long-term respiratory
treatment), neuropsychological symptoms (cerebral
palsy, mental retardation, and neuropsychological
disorders) or orthopedic symptoms (difficulty
walking, physiotherapy, and orthopedic treatment).
The content of the checklist was defined in
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relevant by 3 members of the study group
(a pediatrician, a pediatric surgeon, and a psychologist).
3. Behavior of the child: a brief behavioral screening
was performed using the Strengths and Difficulties
Questionnaire (SDQ) [16]. The SDQ is a 25-item
questionnaire for approximately 3- to 16-year-old
children exploring 5 dimensions: emotional
symptoms (5 items), conduct problems (5),
hyperactivity/inattention (5), peer relationship
problems (5), and prosocial behavior (5). Higher
scores indicate a higher level of difficulties.
Evaluation of the quality of life
The QoL of the children was assessed using the Kidscreen-
27 questionnaire [17], which is a well-validated generic
27-item questionnaire describing 5 dimensions: physical
well-being (5 items), psychological well-being (7 items),
parents and autonomy (4 items), peers and social support
(4 items), and school (4 items). Two versions were avail-
able: a parent version for children under 8 years (the par-
ent assesses the QoL of the child) and a child version for
children aged over 8 years (the child completes the ques-
tionnaire). The level of agreement between children and
their parents was previously assessed [18]. French norms
are available (http://www.kidscreen.org) [19,20].
The QoL of the parents was also assessed using the
Short-Form 36 (SF36) questionnaire, which is a generic
questionnaire used worldwide [21] describing eight sub-
scales (physical function, social functioning, role physical,
role emotional, mental health, vitality, bodily pain, and
general health). Two composite scores (physical and men-
tal) can also be calculated. French norms are available [22].
The scores of the 3 questionnaires ranged between 0
and 100, with higher scores indicating a better QoL.
Statistical analysis
Continuous variables were expressed as the means and
standard deviations and medians and ranges. Qualitative
variables were expressed as percentages. Non-parametric
statistics were employed. The Kidscreen scores of chil-
dren were compared to those obtained from French age-
and sex-matched controls from a normal sample of 1000
subjects [23] and a sample of childhood leukemia survi-
vors of the “L.E.A” cohort (Leucémie de l’Enfant et de
l’Adolescent – childhood and adolescent leukemia), a
French multi-center historical and prospective cohort of
prevalent and incident cases from 2004–2009 [24]. The
SF36 scores [21] of parents were compared to those
obtained from French age- and sex-matched controls
from a normal sample of 3656 subjects [22]. Compari-
sons of mean QoL scores between different sub-groups
(current clinical problems, gender of the child, CDH
side, antenatal diagnosis, and GER at discharge) wereperformed using Mann–Whitney tests. Associations be-
tween QoL scores and continuous variables (age, PICU,
and LOS) were analyzed using Spearman’s correlation
tests. The statistical analyses were performed using SPSS
software package version 17.0 (SPSS Inc., Chicago, IL,
USA). All tests were two sided. Statistical significance
was defined as p < 0.05.
Results
Population
Ninety-nine children were treated for CDH in the two
PICUs during the period. Fifty-seven (57.5%) were
discharged alive. Five of them were excluded from ana-
lysis because the diagnosis was made after maternity dis-
charge. Ten of the 52 remaining families were not
found. The 42 other families agreed to participate in the
study, and parents and children given their informed
consent. Questionnaires were completed by 32 (76.2%)
of the 42 families. Among them, only one has been
treated with ECMO. At the time of observation, 8 (25.0%)
children were less than 4 years old (2.5 ± 0.5 years), 14
(44%) were between 4 and 7 years old (5.1 ± 1.2 years),
and 10 (31%) were 8 or older (10.4 ± 1.6 years). The mean
weight of the children was 22.2 ± 8.9 Kg, and the BMI Z-
score was −1.4 ± 1.9. The characteristics of the population
are reported in Table 1.
Initial management and current clinical problems
The prenatal diagnosis of CDH was made by ultrasound
in 19 (59%) cases at a mean term of 29.0 ± 3.9 weeks of
gestation (WOG). Twelve children born after 2003 under-
went antenatal magnetic resonance imaging. The mean ra-
tio of total/expected pulmonary volume (TPV/EPV) was
74.5 ± 15.6%. The mean term was 38.2 ± 2.8 WOG, and
the mean birth weight was 2996 ± 706 g. Data on birth and
PICU management are reported in Table 1. Ten (31.3%)
neonates were born by cesarean. Four children had associ-
ated malformations: three had upper urinary tract dilata-
tion and one had a T5 hemivertebra. Twenty-four (75.0%)
children were treated by high-frequency oscillation, 23
(71.9%) had aminergic treatment, and 19 (59.4) had INO.
The only treatment with ECMO lasted 9 days. CDH repair
was performed at 2.7 ± 2.3 days (median 1; range 1 – 12
days) after birth. In 3 cases, closure was progressive (6.9
and 12 days) and required a patch. Two children had con-
comitant preventive antireflux surgery. These data are
reported in Table 1.
Twenty-one (65.6%) of the responders had current
clinical problems related to CDH at the time of response.
Digestive issues were found in 11 (34.3%) children, neuro-
logical issues in 3 (9.3%), respiratory issues in 7 (21.9%),
orthopedic issues in 4 (12.5%) and psychological issues
in 7 (21.9%) (Table 2). The SDQ was completed for 24
children. The mean SDQ dimension scores were in the
Table 1 Patients characteristics
1. Characteristics at the time of response N = 32
Gender Girls n (%) 11 (34.4)
Boys n (%) 21 (65.6)
Age (yrs) M±SD 6.7 ± 3.3
m (min/max) 5.8 (2.6/13.8)
Current BMI z-score M±SD −1.4 ± 1.5
m (min/max) −2,1(−4,0/2,2)
CDH side Left n (%) 27 (84.4)
Right n (%) 5 (15.6)
2. Antenatal and neonatal data
Prenatal diagnosis Yes n (%) 19 (59.4)
Birth weight (g) M±SD 2996 ± 709
m (min/max) 3100 (900/4000)
Term (WOG) M±SD 38.2 ± 2.9
m (min/max) 39 (27/41)
Birth weight z-score M±SD −0.5 ± 0.7
m (min/max) 0.6(−2.2/1.2)
Caesarean Yes n (%) 10 (31.3)
Surfactant Yes n (%) 13 (40.6)
MV Duration (d) M±SD 13.0 ± 12.2
m (min/max) 10(1/57)
HFO Yes n (%) 24 (75.0)
Duration (d) M±SD 13.1 ± 13.2
m (min/max) 9 (1/57)
Amines Yes n (%) 23 (71.9)
Duration (d) M±SD 7.4 ± 5.2
m (min/max) 6 (1–26)
NO Yes n (%) 19 (59.4)
Duration (d) M±SD 6.9 ± 7.0
m (min/max) 4 (1–25)
Sedation (d) M±SD 10.7 ± 12.5
m (min-max) 6 (1/57)
ICU LOS (d) M±SD 18.6 ± 18.3
m (min/max) 14 (3/92)
CDH repair (day of life) M±SD 2.7 ± 2.3
m (min/max) 1(1/12)
Surgery Simple 27 (84.4)
Others 5 (15.6)
Hospital LOS (d) M±SD 40.2 ± 34.0
m (min/max) 28(10/140)
Weight at discharge (g) M±SD 3569 ± 829
m (min/max) 3380 (1545/4855)
GER at discharge Yes n(%) 14 (43.8)
WOG week of gestation, LOS length of stay, BMI Body mass index, MV,
mechanical Ventilation, HFO High frequency oscillation, NO nitric oxide, GER
Gastro-esophageal reflux.
M±SD mean±standard deviation, m (min/max), median (minimum/maximum).
Table 2 Current clinical problems of CHD survivors at the
time of response
n (%)
Digestive symptoms (total) 11 (34.4)
Vomiting 3 (9.3)
Gastro-oesophageal reflux 2 (6.3)
Constipation 3 (9.3)
Diarrhea 1 (3.1)
Abdominal pain 3 (9.3)
Medical treatment 3 (9.3)
Respiratory symptoms (total) 7 (21.9)
Dyspnea at rest 2 (6.3)
Exertional dyspnea 3 (9.3)
Nocturn dyspnea 1 (3.2)
Pain chest 0 (0)
Respiratory treatment 2 (6.3)
Repeated respiratory tract infection 4 (12.5)
Hospitalisation for respiratory trouble 3 (9.3)
Neuropsychologic symptoms (total) 8 (26.7)
Cerebral palsy 1 (3.1)
Mental retardation 1 (3.1)
Neurological following 1 (3.1)
Psychological following 7 (21.8)
Orthopedic symptoms (total) 4 (12.5)
Difficult walking 2 (6.3)
Kinesitherapy 2 (6.3)
Orthopedic treatment 1 (3.2)
Total 21 (65.6)
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sponses are shown in Table 3.Quality of life of CDH survivors
The results of these scores are detailed in Table 3: the
highest score was physical well-being, and the lowest
score was the peers and social support score. Of the 5
dimensions of the Kidscreen-27, the scores of CDH sur-
vivors were significantly lower (by more than 12 points)
compared with matched controls (Figure 1 and Table 3).
Compared with 214 long-term survivors of childhood
leukemia, the physical well-being dimension was signifi-
cantly higher for CDH survivors, but there were no dif-
ferences in the 4 other dimensions.Factors modulating the quality of life in CDH survivors
Modulation of children’s QoL
Children with GER at discharge had a significantly poorer
score in 3 dimensions (psychological well-being, parents
Table 3 Self-reported data from the CDH survivors and their parents
1. Children CHD LEA Norms
Children’ QoL: Kidscreen-27 (0–100)* M ± SD Diff (95% CI)+ Diff (95% CI)++
Physical well-being 53.4 ± 10.7 5,9 (1,7 ; 10,1) −11,6 (−15,6 ; -7,63)
Psychological well-being 53.4 ± 9.5 2,3 (−1,5 ; 6,3) −23,8 (−27,2 ; -20,3)
Parents and autonomy 47.3 ± 7.9 −0, (−5,4 ; 3,5) −14,3 (−17,4 ; -11,1)
Peers and social support 44.5 ± 9.5 0,1 (−5,0 ; 5,3) −16,3 (−19,8 ; -12,8)
School 53.5 ± 10.0 3,0 (−1,2 ; 7,3) −13,2 (−17,0 ; -9,44)
Children’ behavioral : SDQ M ± SD
Emotional symptoms 3.0 ± 2.7 - -
Conduct problems 2.5 ± 1.7 - -
Hyperactivity 4.1 ± 2.4 - -
Peer problems 1.6 ± 2.4 - -
Prosocial 8.2 ± 1.5 - -
Total difficulties 11.3 ± 5.7 - -
2. Parents
Parents’ QoL: SF36 (0–100)* M ± SD
Physical function 92.5 ± 13.2 - -
Social functioning 86.7 ± 19.1 - -
Role physical 89.9 ± 15.3 - -
Role emotional 63.2 ± 9.1 - -
Mental health 71.4 ± 14.2 - -
Vitality 71.7 ± 17.0 - -
Body pain 83.8 ± 22.5 - -
General health 79.7 ± 17.3 - -
Physical composite score 55.9 ± 6.1 - -
Mental composite score 46.7 ± 5.6 - -
M±SD mean±standard deviation.
* Higher score, higher QoL level.
LEA long term leucemia survivors, norms, Kidscreen norms (sex- and gender- matched).
+ Diff (95% CI) CHD score – LEA score (95% confidence interval of difference); ++ Diff (95% CI), CHD score – norm score (95% confidence interval of difference).
Figure 1 Comparaison of Kidscreen 27 scores of CDH survivors with long term leucemia survivors (LEA), and norms. * p < 0.001
between sample and Kidscreen norms (sex- and gender- matched). † p < 0.01 between sample and Kidscreen scores of LEA cohort.
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Kidscreen-27. Antenatal diagnosis and length of stay in
the ICU were also associated with lower scores in the
Kidscreen-27 (psychological well-being and parents and
autonomy for antenatal diagnosis and psychological well-
being for length of ICU stay).
Neuropsychological issues in children were associated
with a lower parents and autonomy score in the Kidscreen-
27. Respiratory issues were associated with a lower peers
and social support score.
Gender, age at the time of response, surfactant adminis-
tration, high-frequency oscillation, nitric oxide use, vaso-
pressor use, birth term, birth weight, mechanical ventilation
duration, type of surgery, and orthopedic issues were not
associated with differences in Kidscreen-27 scores.
These results are detailed in Table 4.Parents’ quality of life
There were no differences between the parents of CDH
survivors and matched controls in SF36 scores except for
the role emotional dimension, which was significantly lower
for parents of CDH survivors (Figure 2).Table 4 Children’ quality of life (Kidscreen-27): association with
PhWB
Antenatal diagnosis* Yes 50.0 ± 9.2
No 58.8 ± 11.0
p 0.056
GER at discharge* Yes 49.9 ± 10.3




ICU LOS** Coeff −0.249
p 0.184
Current respiratory problems* Yes 48.3 ± 12.5
No 54.85 ± 9.9
p 0.068
Current digestive problems* Yes 51.9 ± 9.3
No 54.2 ± 11.5
p 0.572
Current neuropsychological problems* Yes 47.3 ± 8.9
No 54.9 ± 10.3
p 0.051
* mean±standard deviation, p p-value Mann–Whitney test.
** Spearman’s correlation coefficient p, p-value Spearman’s test.
PhWB, Physical well-being PsWB, Psychological well-being Par&Au, Parents and auto
higher score represents higher level of QoL.
Bold values, p < 0.05.Modulation of parents’ QoL
The mental component score in the SF36 of parents of
CDH survivors was significantly altered in cases of
right-sided CDH, antenatal diagnosis and GER at dis-
charge. GER at discharge was also associated with a
lower score in the general health and role physical di-
mensions. Difficult abdominal closure was associated
with a lower bodily pain dimension score and physical
component score, while a higher age of children at
the moment of response was associated with a poorer
physical functioning dimension score, and a longer
ICU stay was associated with a lower role physical di-
mension score. The gender of the child, age at the
moment of response, surfactant administration, high-
frequency oscillation, nitric oxide use, vasopressor use,
birth term, birth weight, and mechanical ventilation
duration were not associated with differences in the
SF36 score.
These results are detailed in Table 5.
Discussion
The most important finding of this study is that CDH
survivors have an altered QoL compared with controlssocio-demographic parameters and initial management
PsWB ParAu PSS Sch
49.0 ± 6.6 45.0 ± 8.9 44.2 ± 10.6 51.0 ± 9.0
60.3 ± 9.6 50.5 ± 5.3 45.1 ± 7.8 57.3 ± 10.6
0.003 0.035 0.613 0.114
48.9 ± 7.5 43.7 ± 8.1 40.5 ± 10.0 50.7 ± 8.4
57.0 ± 9.7 50.7 ± 6.2 48.0 ± 7.9 55.8 ± 10.8
0.016 0.009 0.013 0.213
−0.020 0.099 0.358 0.047
0.914 0.639 0.062 0.807
−0.397 −0.062 0.374 −0.281
0.03 0.772 0.055 0.140
53.6 ± 10.5 42.2 ± 7.7 38.2 ± 7.5 56.6 ± 12.3
53.28 ± 9.5 49.02 ± 7.4 46.66 ± 9.3 52.78 ± 9.5
0.924 0.074 0.031 0.334
51.2 ± 7.2 48.5 ± 7.9 45.9 ± 12.1 51.9 ± 5.9
54.5 ± 10.6 46.8 ± 8.09 43.7 ± 7.69 54.4 ± 11.6
0.504 0.600 0.832 0.506
51.5 ± 9.1 41.3 ± 6.6 39.8 ± 8.0 48.4 ± 9.2
54.2 ± 10.3 48.3 ± 6.8 44.9 ± 8.8 55.5 ± 10.3
0.657 0.042 0.200 0.101









Figure 2 Comparisons of SF36 dimensions scores between the parents of CDH survivors and norms. * p < 0.05 between sample and
SF-36 norms (sex- and gender- matched).
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pathology associated with long-term consequences (child-
hood leukemia survivors). As expected, the physical dimen-
sion is altered in CDH survivors, but the score remains
higher than the score of childhood leukemia survivors, who
are faced to a severe disease and known to have severe
physical sequelae [23].
Nearly two thirds of CDH survivors have clinical prob-
lems. The most frequently reported problems are gastro-
intestinal issues. Similar data had already been reported
in previous studies. We show here that these issues se-
verely impact QoL.
Behavioral issues can be an important determinant of
QoL. We explored this problem using the SDQ. Recent
data have proposed SDQ norms for French children
[25]. All mean sub-scores in our population were in the
normal range. However, this questionnaire did not test
mild issues, such as attention and concentration deficit
reported by Peetsold et al. [15].
At discharge, CDH survivors have a good vital prognosis
but are not cured and require attentive evaluation and
management of long-term morbidity to limit QoL alter-
ation. Our data suggest a lower QoL than 2 previous stud-
ies [12,14]. Several reasons can explain these differences.
One explanation could be the sample characteristics. In
Peetsold’s study, the authors used the Child Health Ques-
tionnaire (CHQ) to explore the QoL of CDH child survi-
vors aged 6 to 16 years [15]. The authors showed that the
level of QoL did not differ from norms, except for general
health perception and physical functioning in the CHQ-
PF50 (completed by parents of children younger than 10
years) and general health perception in the CHQ-CF87
(completed by children 10 years old and older). The chil-
dren in that study were born between 1987 and 1999.Therapeutic management has been progressively modified
during this period, and it is possible that some children
did not receive all the treatments that are currently avail-
able. For example, the first clinical report of INO use was
published in 1992 [26]. Therefore, survivors were probably
the less serious cases, had less sequelae and higher quality
of life in childhood. In our study, we chose the period after
1999 to ensure that the most recent treatments were used.
The second published study compared the QoL of 111
CDH survivors with the QoL of 286 survivors of congeni-
tal anorectal malformation and a control group [13]. Fifty-
nine CDH child survivors between 1 and 16 years were
included. The authors found that both physical and psy-
chological/emotional dimensions were altered. In that
study, all the patients were born before 1996, meaning that
most of the children were not treated according to most
recent recommendations. Furthermore, the results were
expressed by different age groups, limiting data analysis.
A second explanation of the discrepancies between
our results and previous findings may rely on the modal-
ities of QoL assessment. In the two previous studies,
QoL was assessed using well-validated questionnaires,
but the content of these questionnaires relied on either
the literature or experts to determine the domains and
concerns that are important for the individuals, although
it is now generally accepted that the content of QoL
measures should be directly derived from affected indi-
viduals [27]. The questionnaire used in our study, the
Kidscreen questionnaire, is based on both literature and
focus groups (children, parents and workers in the field).
The choice of the QoL questionnaires can also be dis-
cussed. Poley et al. [13] used the Taiqol questionnaire,
which has two different non-mergeable versions according
to age, to evaluate the QoL, restricting the significance of
Table 5 Parents’ quality of life (SF36): associations with socio-demographic parameters and initial management
PF SF RP RE MH Vi BP GH PCS MCS
Antenatal diagnosis* Yes 91.5 ± 15.7 82.6 ± 22.3 87.5 ± 16.2 61.6 ± 10.4 68.5 ± 13.9 67.4 ± 16.3 80.4 ± 23.8 75.0 ± 18.9 55.0 ± 6.7 45.1 ± 5.7
No 93.8 ± 9.2 92.3 ± 12.0 93.3 ± 13.8 65.4 ± 6.7 75.8 ± 14.1 78.1 ± 16.5 88.5 ± 20.6 86.8 ± 12.1 57.3 ± 5.1 49.0 ± 4.9
p 0.683 0.301 0.185 0.508 0.134 0.072 0.245 0.085 0.290 0.038
Surgery* Simple 92.8 ± 14.1 87.8 ± 19.2 91.8 ± 14.0 62.2 ± 8.6 71.1 ± 14.9 72.0 ± 18.0 87.1 ± 21.8 80.8 ± 16.0 56.9 ± 5.6 46.3 ± 5.9
Others 91.0 ± 8.2 85.0 ± 20.5 80.0 ± 19.5 68.3 ± 10.9 73.0 ± 11.0 70.0 ± 12.0 66.4 ± 19.6 74.0 ± 24.1 51.1 ± 7.0 48.7 ± 4.3
p 0.238 0.637 0.091 0.329 0.955 0.933 0.014 0.655 0.048 0.254
GER at discharge* Yes 93,7 ± 3,2 83,0 ± 6,2 87,0 ± 3,7 60,7 ± 2,8 69,8 ± 3,6 66,9 ± 3,4 84,1 ± 6,7 70,8 ± 5,0 55,2 ± 1,6 45,0 ± 1,4
No 91,5 ± 3,5 89,7 ± 3,6 92,3 ± 4,0 65,2 ± 1,8 72,8 ± 3,8 75,78 ± 4,9 83,5 ± 5,1 87,4 ± 3,0 56,5 ± 1,6 48,1 ± 1,4
p 0,848 0,711 0,029 0,304 0,487 0,159 0,794 0,008 0,339 0,042
Age** Coeff −0.378 −0.174 0.212 −0.262 −0.204 −0.132 −0.142 −0.110 −0.147 −0.154
p 0.036 0.348 0.252 0.155 0.281 0.488 0.446 0.564 0.437 0.417
ICU LOS** Coeff −0.019 −0.201 −0.417 −0.111 −0.023 −0.189 −0.291 −0.289 −0.350 −0.042
p 0.919 0.286 0.022 0.558 0.904 0.325 0.118 0.128 0.063 0.829
Current respiratory problems* Yes 87,0 ± 19,0 71,4 ± 25,7 87,5 ± 19,1 63,1 ± 6,6 72,9 ± 15,2 64,3 ± 13,8 68,1 ± 32,2 63,9 ± 24,8 50,8 ± 8,6 45,9 ± 5,0
No 94,1 ± 11,0 91,1 ± 14,5 90,6 ± 14,4 63,2 ± 9,8 71,0 ± 14,2 73,9 ± 17,4 88,3 ± 17,2 84,5 ± 11,2 57,5 ± 4,3 46,9 ± 5,9
p 0,068 0,038 0,980 0,958 0,637 0,399 0,147 <0.001 0,059 0,391
Current digestive problems* Yes 90,4 ± 14,3 83,8 ± 22,0 90,0 ± 15,3 65,0 ± 9,5 65,8 ± 17,1 70,6 ± 15,6 78,7 ± 27,0 76,1 ± 15,8 55,1 ± 5,8 45,4 ± 6,7
No 93,5 ± 12,8 88,1 ± 17,8 89,9 ± 15,6 62,3 ± 8,98 74,3 ± 11,9 72,2 ± 17,9 86,2 ± 20,3 81,5 ± 18,1 56,3 ± 6,35 47,3 ± 5,13
p 0,248 0,642 0,787 0,727 0,174 0,824 0,342 0,320 0,356 0,509
Current neuropsychological problems* Yes 96,3 ± 5,2 90,6 ± 18,6 90,6 ± 10,0 62,5 ± 14,1 70,3 ± 11,1 68,8 ± 14,2 88,6 ± 20,6 70,5 ± 18,7 56,2 ± 6,0 46,0 ± 5,7
No 92,7 ± 13,3 86,3 ± 19,7 91,1 ± 15,1 63,9 ± 6,6 72,5 ± 15,3 74,1 ± 18,2 80,4 ± 23,8 83,5 ± 16,6 56,0 ± 6,5 47,3 ± 5,7
p 0,751 0,396 0,348 0,914 0,367 0,400 0,384 0,055 0,959 0,476
* mean±standard deviation p, p-value Mann–Whitney test.
** Spearman’s correlation coefficient p, p-value Spearman’s test.
PF physical functioning, SF social functioning, RP role physical, RE role-emotional, MH mental health, VI vitality, BP bodily pain, GH general health, PCS physical composite score MCS, mental composite score, higher
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http://www.ojrd.com/content/8/1/89the results. The Kidscreen allows for merging child and
adolescent scores.
The important results of our study are the potential
determinants of QoL, which were poorly explored in pre-
vious studies, although the small sample size prevented
multivariate analysis. Several parameters were linked to
QoL in univariate analysis and could help clinicians to
identify children with a high risk of having altered QoL
early. The first parameter was prenatal diagnosis, which
was associated with lower QoL. An explanation of this re-
sult is that prenatally undiagnosed CDH is associated with
lower severity. Pathophysiology of CDH is complex and
not yet completely elucidated, however a “dual hit” patho-
genesis [28] is widely admitted. Abnormal development,
early in the pregnancy causes diaphragmatic defect and
development troubles affecting both lungs. Secondly, com-
pression by bowel herniation causes hypoplasia. We hy-
pothesis to explain our findings, that when the hernia
occurs late in pregnancy the diagnosis is not made because
CDH occurs at the end of gestation after ultrasound con-
trol in the third trimester. In these cases, pulmonary con-
sequences caused by the “second hit” could be lower,
decreasing impact lung functioning at birth [29].
Gastroesophageal reflux is a major complication of CDH
and one of the most reported complaints of patients [30].
The presence of GER at discharge is associated with a
lower score in 3 dimensions of the Kidscreen-27 and 3 di-
mensions in the SF36 in parents. As widely reported in the
literature, GER is frequent in this population and requires
early diagnosis and treatment. Interestingly, digestive is-
sues, including GER, at the time of the response were not
linked with lower children’s QoL. GER at discharge most
likely reflects the severity of disease and may be associated
with several problems responsible for issues impacting
QoL later.
The ICU length of stay was associated with a lower
QoL in CDH survivors. The hospital length of stay had
been found as the only factor associated with lower QoL
by Peetsold et al. [15]. These results are concordant and
confirm that QoL alteration occurs for the most severe
patients. Furthermore, excepted the disease and its se-
quelae, congenital malformation [31] and ICU hospital-
ization [32] at birth can be responsible by themselves for
parental attachment troubles with late consequences in
parents/child relation and possible impact on QoL.
Unlike others authors who found a lower QoL in youn-
ger children, we did not find any correlation between age
and Kidscreen score. A possible explanation is that the
QoL of CDH survivors improves after 10 or 12 years, and
we did not explore this older population in our study,
while other authors included children up to 16 years.
We found few differences between the QoL of parents
of CDH survivors and controls; however, the emotional
dimension score was lower in parents of CDH survivors,which is in agreement with a previous study in which
the authors explored the QoL of the family and parents
of 53 CDH survivors [14] using the Child Health Ratings
Inventories General Health Module Parent Report. This
questionnaire does not explore all domains of QoL; for
example, it neglects social aspects. In that study, the
children were born between 1991 and 1999 during the
modification period of therapeutic management of CDH.
We chose to use the SF36 questionnaire, which is the
most widely used questionnaire to evaluate QoL in adults.
However, the parenthood status of the norms was not avail-
able. It is well-know that the process of becoming/being
parent or being childless may influence the QoL [33,34].
Future studies should specifically study the parenting influ-
ence. For the first time to our knowledge, the QoL of CDH
survivors and the QoL of their parents were simultaneously
measured.
Several limitations of our study must be mentioned. The
sample size did not allow for a multivariate approach ac-
counting for potential confounding factors, and moderate
associations were possibly missed due to low power. This
limitation is a frequent problem in this area. Nevertheless
we can assume that a majority of individuals with CHD
living in the geographic area had access to the participant
centers. Replication of these findings in larger groups of
patients is required. For the same reason, ECMO was not
analyzed because only one child in this study was treated
by ECMO. ECMO as rescue can lead to specific morbidity
and could significantly impact the QoL of CDH survivors.
Another important problem is that some data have been
retrospectively collected, which may lead to bias. For ex-
ample, we could not evaluate and compare the severity of
patients because admission severity scores were poorly
reported on charts and different between participating
PICUs. Furthermore, although it appears that pregnancy
termination for CDH is rare in our prenatal medical cen-
ter, we have no reliable data to confirm this hypothesis.
Therefore, the high mortality rate observed cannot be
interpreted as poor results of treatment. Similarly, initial
ultrasound and MRI results were not available for enough
patients to be included in univariate analysis. A third limi-
tation is that the questionnaires were sent by mail, and we
did not meet the children or their family. This increases
the missing data rate and decreases the reliability of re-
sponses to clinical data. We considered that hearing and
vision problems, which are frequently reported in CDH
survivors, were too subjective to be evaluated by a postal
questionnaire. Future research should be provided medical
data based on clinical assessments.
In conclusion, this is the first study providing data on
CDH child survivors treated according to the most re-
cent practices, and for the first time, the QoL of children
and their parents was studied simultaneously. The im-
pact of CDH on QoL seems to be important and must
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http://www.ojrd.com/content/8/1/89be understood by clinicians who treat these children and
their parents. Prenatal diagnosis and GER at discharge
are two markers of QoL alteration and must be consid-
ered by clinicians. Finally, all existing studies include a
small number of patients, limiting the interpretation of
results. It is important to perform multicentric studies
to better evaluate the QoL of these patients and its
determinants.
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